drugset / Trial / NCT04602143

Effect of Testosterone Pretreatment in POR

NCT04602143

RandomizedParallel-groupSingle-blindTreatment

Summary

This study compared the therapeutic effect of 4- and 6-week TTG application before controlled ovarian hyperstimulation (COH) in POR.

Timeline

Start
2018-02-16
Primary completion
2020-06-30
Completion
2020-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 12.5 mg Topical

Indications